The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
A neostriatal habit learning system in humans
Knowlton, B. J., Mangels, J. A., & Squire, L. R. (1996) · Science · doi:10.1126/science.273.5280.1399 · Cited by 1,777
Differential Effects of Early Hippocampal Pathology on Episodic and Semantic Memory
Vargha-Khadem, F., Gadian, D. G., Watkins, K. E., Connelly, A., Van Paesschen, W., & Mishkin, M. (1997) · Science · doi:10.1126/science.277.5324.376 · Cited by 1,746
Tariot, P. N., Farlow, M. R., Grossberg, G. T., Graham, S. M., McDonald, S., Gergel, I., & for the Memantine Study Group (2004) · JAMA · doi:10.1001/jama.291.3.317 · Cited by 1,403
Bechara, A., Tranel, D., Damasio, H., Adolphs, R., Rockland, C., & Damasio, A. R. (1995) · Science · doi:10.1126/science.7652558 · Cited by 1,400
McShane, R., Areosa Sastre, A., & Minakaran, N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154.pub5 · Cited by 1,155
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,063
Graded persistent activity in entorhinal cortex neurons
Egorov, A. V., Hamam, B. N., Fransén, E., Hasselmo, M. E., & Alonso, A. A. (2002) · Nature · doi:10.1038/nature01171 · Cited by 769
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
Senile dementia of Lewy body type
Perry, R. H., Irving, D., Blessed, G., Fairbairn, A., & Perry, E. K. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90236-g · Cited by 571
Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease
Mutisya, E. M., Bowling, A. C., & Beal, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062179.x · Cited by 531
A Controlled, Randomized, Delayed-Start Study of Rasagiline in Early Parkinson Disease
(2004) · Archives of Neurology · doi:10.1001/archneur.61.4.561 · Cited by 485
Reversible neural inactivation reveals hippocampal participation in several memory processes
Riedel, G., Micheau, J., Lam, A. G. M., Roloff, E. V. L., Martin, S. J., Bridge, H., Hoz, L. D., Poeschel, B., McCulloch, J., & Morris, R. G. M. (1999) · Nature Neuroscience · doi:10.1038/13202 · Cited by 481
Impaired Recognition Memory in Monkeys after Damage Limited to the Hippocampal Region
Zola, S. M., Squire, L. R., Teng, E., Stefanacci, L., Buffalo, E. A., & Clark, R. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00451.2000 · Cited by 477
Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases
Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., & Youdim, M. B. H. (1990) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252926 · Cited by 445
Self-citationThe Occurrence of Depression in Parkinson's Disease: A Community-Based Study
Tandberg, E. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020087019 · Cited by 409
Saura, J., Luque, J. M., Cesura, A. M., Prada, M. D., Chan-Palay, V., Huber, G., Löffler, J., & Richards, J. G. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90311-5 · Cited by 382
Cassarino, D. S., & Bennett, J. P. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00046-0 · Cited by 379
Brain iron pathways and their relevance to Parkinson's disease
Berg, D., Gerlach, M., Youdim, M. B. H., Double, K. L., Zecca, L., Riederer, P., & Becker, G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00608.x · Cited by 362
Self-citationGr�nblatt, E., Mandel, S., Jacob-Hirsch, J., Zeligson, S., Amariglo, N., Rechavi, G., Li, J., Ravid, R., Roggendorf, W., Riederer, P., et al. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0212-1 · Cited by 356
Self-citationYoudim, M. B. H., Gross, A., & Finberg, J. P. M. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703826 · Cited by 342
Self-citationWeinstock, M. (1999) · CNS Drugs · doi:10.2165/00023210-199912040-00005 · Cited by 278
Vann, S. D., Brown, M. W., Erichsen, J. T., & Aggleton, J. P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02711.2000 · Cited by 260
Cassel, J.-C., & Jeltsch, H. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00241-a · Cited by 256
Sterling, J., Herzig, Y., Goren, T., Finkelstein, N., Lerner, D., Goldenberg, W., Miskolczi, I., Molnar, S., Rantal, F., Tamas, T., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020120c · Cited by 247
Self-citationShachar, D. B., Kahana, N., Kampel, V., Warshawsky, A., & Youdim, M. B. H. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.005 · Cited by 246
Self-citationGrünblatt, E., Mandel, S., Maor, G., & Youdim, M. B. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00397.x · Cited by 246
Self-citationMedial temporal and prefrontal contributions to working memory tasks with novel and familiar stimuli
Stern, C. E., Sherman, S. J., Kirchhoff, B. A., & Hasselmo, M. E. (2001) · Hippocampus · doi:10.1002/hipo.1048 · Cited by 245
Rivastigmine, a New‐Generation Cholinesterase Inhibitor for the Treatment of Alzheimer's Disease
Jann, M. W. (2000) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.1.1.34664 · Cited by 236
YOUDIM, M. B. H., STEPHENSON, G., & SHACHAR, D. B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.025 · Cited by 233
Self-citationThe Role of Iron in Neurodegeneration: Prospects for Pharmacotherapy of Parkinson??s Disease
Jellinger, K. A. (1999) · Drugs & Aging · doi:10.2165/00002512-199914020-00004 · Cited by 218
Possible neurotransmitter basis of behavioral changes in alzheimer's disease
Palmer, A. M., Stratmann, G. C., Procter, A. W., & Bowen, D. M. (1988) · Annals of Neurology · doi:10.1002/ana.410230616 · Cited by 194
Memory for Spatial Location: Role of the Hippocampus in Mediating Spatial Pattern Separation
Gilbert, P. E., Kesner, R. P., & DeCoteau, W. E. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00804.1998 · Cited by 190
Neuroprotection via pro‐survival protein kinase C isoforms associated with Bcl‐2 family members
Weinreb, O., Bar‐Am, O., Amit, T., Chillag‐Talmor, O., & Youdim, M. B. H. (2004) · The FASEB Journal · doi:10.1096/fj.04-1916fje · Cited by 187
Self-citationGsell, W., Conrad, R., Hickethier, M., Sofic, E., Frölich, L., Wichart, I., Jellinger, K., Moll, G., Ransmayr, G., Beckmann, H., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64031216.x · Cited by 175
MATTSON, M. P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.004 · Cited by 164
How Does the Brain Organize Memories?
Eichenbaum, H. (1997) · Science · doi:10.1126/science.277.5324.330 · Cited by 161
Nicotine enhances delayed matching-to-sample performance by primates
Elrod, K., Buccafusco, J. J., & Jackson, W. J. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90318-9 · Cited by 142
Self-citationHuang, W., Chen, Y., Shohami, E., & Weinstock, M. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00929-7 · Cited by 141
Youdim, M. B. H., WADIA, A., Tatton, W. G., & Weinstock, M. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03656.x · Cited by 140
Self-citationWeinstock, M., Bejar, C., Wang, R.-H., Poltyrev, T., Gross, A., Finberg, J. P. M., & Youdim, M. B. H. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_10 · Cited by 124
Self-citationYoudim, M. B. H., Fridkin, M., & Zheng, H. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0143-x · Cited by 123
Self-citationTeng, E., Stefanacci, L., Squire, L. R., & Zola, S. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03853.2000 · Cited by 121
The prevalence of depression in Alzheimer's disease and vascular dementia in a population sample
Newman, S. C. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00070-6 · Cited by 115
Comparison of Extrapyramidal Signs in Dementia With Lewy Bodies and Parkinson's Disease
Aarsland, D., Ballard, C. G., McKeith, I. G., Perry, R. H., & Larsen, J. O. (2001) · Journal of Neuropsychiatry · doi:10.1176/jnp.13.3.374 · Cited by 108
Multiple Central Nervous System Targets for Eliciting Beneficial Effects on Memory and Cognition
Buccafusco, J. J., & Terry, A. V. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38924-4 · Cited by 107
Self-citationYogev‐Falach, M., Amit, T., Bar‐Am, O., Weinstock, M., & Youdim, M. B. H. (2002) · The FASEB Journal · doi:10.1096/fj.02-0198fje · Cited by 105
Self-citationCognitive and Behavioral Effects of Cholinergic, Dopaminergic, and Serotonergic Blockade in Humans
Vitiello, B., Martin, A., Hill, J., Mack, C., Molchan, S., Martinez, R., Murphy, D. L., & Sunderland, T. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00134-0 · Cited by 101
Maruyama, W., Weinstock, M., Youdim, M. B. H., Nagai, M., & Naoi, M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00211-8 · Cited by 100
Self-citationMaruyama, W., Akao, Y., Youdim, M. B. H., & Naoi, M. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_11 · Cited by 99
Self-citationMoretti, R., Torre, P., Antonello, R. M., & Cazzato, G. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00224.x · Cited by 87
Wenk, G. L., McGann-Gramling, K. R., Hauss‐Wegrzyniak, B., Ronchetti, D., Maucci, R., Rosi, S., Gasparini, L., & Ongini, E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02359.x · Cited by 85
Lidow, M. S., Koh, P., & Arnsten, A. F. T. (2002) · Synapse · doi:10.1002/syn.10143 · Cited by 84
Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats
Haroutunian, V. H., Kanof, P. D., Tsuboyama, G. K., & Davis, K. L. (1990) · Brain Research · doi:10.1016/0006-8993(90)90280-o · Cited by 83
Maclean, L. E., Collins, C., & Byrne, E. J. (2001) · International Psychogeriatrics · doi:10.1017/s1041610201007670 · Cited by 80
Sybirska, E. H., Davachi, L., & Goldman‐Rakic, P. S. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05827.2000 · Cited by 75
Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders
Speiser, Z., Levy, R., & Cohen, S. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6499-0_29 · Cited by 74
Weinstock, M., Gorodetsky, E. K., Poltyrev, T., Gross, A., Sagi, Y., & Youdim, M. B. H. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00053-8 · Cited by 72
Self-citationUsing cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs
Mandel, S. A., Weinreb, O., & Youdim, M. B. H. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00067-1 · Cited by 69
Self-citationGALANTAMINE: A REVIEW OF ITS USE IN ALZHEIMER'S DISEASE AND VASCULAR DEMENTIA
Corey, J. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10467.x · Cited by 69
Little, J. T., Johnson, D. N., Minichiello, M., Weingartner, H., & Sunderland, T. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00002-5 · Cited by 66
Terry, A. V., Jackson, W. J., & Buccafusco, J. J. (1993) · Cerebral Cortex · doi:10.1093/cercor/3.4.304 · Cited by 64
Self-citationSagi, Y., Weinstock, M., & Youdim, M. B. H. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01801.x · Cited by 62
Self-citationFranowicz, J. S., & Arnsten, A. F. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00060-3 · Cited by 62
Weinstock, M., Poltyrev, T., Bejar, C., & Youdim, M. B. H. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0978-x · Cited by 61
Self-citationGalantamine: a review of its use in Alzheimer's disease and vascular dementia.
Corey‐Bloom, J. (2003) · PubMed · Cited by 60
Meredith, G. E., Halliday, G. M., & Totterdell, S. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.01.001 · Cited by 57
Rasagiline: an anti-Parkinson drug with neuroprotective activity
Youdim, M. B. H. (2003) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.3.6.737 · Cited by 49
Self-citationRowe, W. B., O’Donnell, J.-P., Pearson, D., Rose, G. M., Meaney, M. J., & Quirion, R. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00116-5 · Cited by 39
Weinstock, M., Gorodetsky, E. K., Wang, R. H., Gross, A., Weinreb, O., & Youdim, M. B. H. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00176-4 · Cited by 37
Self-citationCognitive effects of nicotinic cholinergic receptor agonists in nonhuman primates
Buccafusco, J. J., Prendergast, M., Terry, A. V., & Jackson, W. J. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(199607/08)38:3/4<196::aid-ddr8>3.0.co;2-h · Cited by 35
Self-citationThe role of dopamine in cognition: evidence from functional imaging studies
Rémy, P., & Samson, Y. (2003) · Current Opinion in Neurology · doi:10.1097/00019052-200312002-00007 · Cited by 34
(2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7867-8 · Cited by 33
Buccafusco, J. J., Terry, A. V., Goren, T., & Blaugrun, E. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00937-5 · Cited by 32
Self-citationDifferential Activation of Adenylyl Cyclases by Spatial and Procedural Learning
Guillou, J., Rose, G. M., & Cooper, D. M. F. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-14-06183.1999 · Cited by 31
Furlan, R., Kurne, A., Bergami, A., Brambilla, E., Maucci, R., Gasparini, L., Butti, E., Comı, G., Ongini, E., & Martino, G. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.01.004 · Cited by 26
Li, X. D., & Buccafusco, J. J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063321 · Cited by 25
Self-citationBinder, M. D., Hirokawa, N., & Windhorst, U. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_1112 · Cited by 8
The cholinergic hypothesis — past and present
Buccafusco, J. J. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7867-8_1 · Cited by 5
Self-citationDrugs that target serotonergic receptors
Terry, A. V. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7867-8_6 · Cited by 4
Cited by
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
Self-citationThe therapeutic potential of monoamine oxidase inhibitors
Youdim, M. B. H., Edmondson, D., & Tipton, K. F. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1883 · Cited by 1,363
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Polypharmacology: Challenges and Opportunities in Drug Discovery: Miniperspective
Anighoro, A., Bajorath, J., & Rastelli, G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5006463 · Cited by 1,131
A perspective on multi‐target drug discovery and design for complex diseases
Ramsay, R. R., Popovic‐Nikolic, M. R., Nikolic, K., Uliassi, E., & Bolognesi, M. L. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0181-2 · Cited by 718
Metadata
- Authors
- Youdim, M. B. H., & Buccafusco, J. J.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 26
- Issue
- 1
- Pages
- 27-35
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W1998596454
- Cited by
- 380
- References
- 80
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.